An experimental drug that targets macrophages, a type of immune cell, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists reported at the American Society for Cell Biology (ASCB) annual meeting in New Orleans.
19 Dec, 2013
-
Source:
http://www.medicalnewstoday.com/releases/270241.php--
Manage subscription | Powered by
rssforward.com
0 comments:
Post a Comment